Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Shu-Yein HoChia-Yang HsuPo-Hong LiuRheun-Chuan LeeChih-Chieh KoYi-Hsiang HuangChien-Wei SuMing-Chih HouTeh-Ia Huo

Published in: Digestive diseases and sciences (2020)

The ALBI grade-based prognostic model can well discriminate the survival in HCC patients undergoing TACE. The proposed easy-to-use nomogram may accurately predict the survival at 3 and 5 years for individual HCC patient in the precision medicine era.

Keyphrases

patients undergoing
lymph node metastasis
radiofrequency ablation
free survival
case report
squamous cell carcinoma